Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome

1. Child, F.
2. Ortiz-Romero, P.L.
3. Alvarez, R.
4. Bagot, M.
5. Stadler, R.
6. Weichenthal, M.
7. Alves, R.
8. Quaglino, P.
9. Beylot-Barry, M.
10. Cowan, R.
11. Geskin, L.J.
12. Pérez-Ferriols, A.
13. Hellemans, P.
14. Elsayed, Y.
15. Phelps, C.
16. Forslund, A.
17. Kamida, M.
18. Zinzani, P.L.